Keyphrases
Dose Effect
100%
Neuroprotection
100%
Neurturin
100%
AAV2
100%
Motor Neuron
33%
Neuromuscular Junction
33%
Cervical Spinal Cord
33%
Neurotrophic Factors
33%
Tolerability
16%
Neuroprotective Effect
16%
Disease Progression
16%
Clinical Trials
16%
Lumbar Spinal Cord
16%
Clinical Experience
16%
Recombinant Adeno-associated Virus (rAAV)
16%
Biodistribution
16%
Parkinson's Disease Model
16%
Serum Blood
16%
ALS Patients
16%
Patients with Parkinson's Disease
16%
Behavioral Improvement
16%
Preclinical Safety
16%
Virus Serotype
16%
Blood Count
16%
Serotype 2
16%
Preclinical Efficacy
16%
Drug-related Deaths
16%
Serum Chemistry
16%
SOD1G93A Mice
16%
Neurotrophic Agents
16%
Strength Degradation
16%
ALS Model
16%
Forelimb Grip Strength
16%
Neuroscience
Neuroprotection
100%
Neurturin
100%
Neuromuscular Junction
33%
Parkinson's Disease
33%
Motor Neuron
33%
Neurotrophic Factor
33%
Adeno-Associated Virus
16%
Neuroprotective Agent
16%
Synapse
16%
Pharmacology, Toxicology and Pharmaceutical Science